Gross Margin Improved 300 basis points to 31% Year-Over-Year
Adjusted EBITDA Grew 30% Year-Over-Year
EPS Grew 45% Year-Over-Year
TAMPA, Fla., April 12, 2024 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, today reported its financial results for the fourth quarter and year ended December 31, 2023.
Kent Cunningham, CEO of Better Choice, stated, “In 2023, we realized significant gross margin improvement to 31%, fueled by strategic pricing initiatives and a 3% YOY improvement of input costs – a reflection of operational discipline and unlocking profit through high production supply volumes. Our further continued focus on financial discipline and a path to profitability is reflected in the 29% adjusted EBITDA growth and significant improvement in cash burn during the year. The topline decline was a primary result of normalizing stock levels in our International markets, purposefully exiting unprofitable accounts, and attrition related to the late 2022 migration of the former TruDog brand to the Halo brand umbrella in our digital channels. Significant strategic shifts were purposefully made across channels to ensure recoverability and long-term viability of the Halo brand. Our 2024 annual operating plan includes a strategic pivot in our digital and marketing investment allocation strategies to drive brand growth and discoverability. Looking forward, we are focused on accelerating topline momentum, keeping product quality at the forefront, and continuous improvement initiatives to fuel our future growth trajectory. We closed the year with a solid footing to build upon brand equity and enhanced profitability further in 2024.”
FOURTH QUARTER 2023 FINANCIAL HIGHLIGHTS
FULL YEAR 2023 FINANCIAL HIGHLIGHTS
Better Choice Company Inc. Unaudited Condensed Consolidated Statements of Operations (Dollars in thousands, except share and per share amounts) |
|||||||
Year Ended December 31, | |||||||
2023 | 2022 | ||||||
Net sales | $ | 38,592 | $ | 54,660 | |||
Cost of goods sold | 26,795 | 39,399 | |||||
Gross profit | 11,797 | 15,261 | |||||
Operating expenses: | |||||||
Selling, general and administrative | 24,444 | 35,430 | |||||
Impairment of goodwill | — | 18,614 | |||||
Impairment of intangible assets | 8,532 | ||||||
Total operating expenses | 32,976 | 54,044 | |||||
Loss from operations | (21,179 | ) | (38,783 | ) | |||
Other expenses: | |||||||
Interest expense, net | (1,353 | ) | (551 | ) | |||
Change in fair value of warrant liability | (236 | ) | — | ||||
Total other expense, net | (1,589 | ) | (551 | ) | |||
Net loss before income taxes | (22,768 | ) | (39,334 | ) | |||
Income tax expense (benefit) | 2 | (18 | ) | ||||
Net loss available to common stockholders | $ | (27,770 | ) | $ | (39,316 | ) | |
Weighted average number of shares outstanding, basic | 705,185 | 667,114 | |||||
Weighted average number of shares outstanding, diluted | 705,185 | 667,114 | |||||
Net loss per share available to common stockholders, basic | $ | (32.29 | ) | $ | (58.93 | ) | |
Net loss per share available to common stockholders, diluted | $ | (32.29 | ) | $ | (58.93 | ) | |
All share and per share amounts related to the Company’s common stock for all periods presented herein have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. | |||||||
Better Choice Company Inc. Unaudited Condensed Consolidated Balance Sheets (Dollars in thousands, except share and per share amounts) |
|||||||
December 31, 2023 | December 31, 2022 | ||||||
Assets | |||||||
Cash and cash equivalents | $ | 4,455 | $ | 3,173 | |||
Restricted cash | — | 6,300 | |||||
Accounts receivable, net | 4,354 | 6,744 | |||||
Inventories, net | 6,611 | 10,257 | |||||
Prepaid expenses and other current assets | 812 | 1,051 | |||||
Total Current Assets | 16,232 | 27,525 | |||||
Fixed assets, net | 230 | 375 | |||||
Right-of-use assets, operating leases | 120 | 173 | |||||
Intangible assets, net | — | 10,059 | |||||
Other assets | 155 | 544 | |||||
Total Assets | $ | 16,737 | $ | 38,676 | |||
Liabilities & Stockholders’ Equity | |||||||
Current Liabilities | |||||||
Accounts payable | $ | 6,928 | $ | 2,932 | |||
Accrued and other liabilities | 2,085 | 2,596 | |||||
Line of credit | 1,741 | – | |||||
Term loan, net | 2,881 | – | |||||
Operating lease liability | 57 | 52 | |||||
Total Current Liabilities | 13,692 | 5,580 | |||||
Non-current Liabilities | |||||||
Line of credit, net | — | 11,444 | |||||
Operating lease liability | 67 | 124 | |||||
Total Non-current Liabilities | 67 | 11,568 | |||||
Total Liabilities | 13,759 | 17,148 | |||||
Stockholders’ Equity | |||||||
Common Stock, $0.001 par value, 200,000,000 shares authorized, 729,026 & 668,869 shares issued and outstanding as of December 31, 2023, and December 31, 2022, respectively | 32 | 29 | |||||
Additional paid-in capital | 324,288 | 320,071 | |||||
Accumulated deficit | (313,342 | ) | (298,572 | ) | |||
Total Stockholders’ Equity | 2,978 | 21,528 | |||||
Total Liabilities and Stockholders’ Equity | $ | 16,737 | $ | 38,676 | |||
Better Choice Company Inc. Non-GAAP Measures |
Adjusted EBITDA
We define Adjusted EBITDA as EBITDA further adjusted to eliminate the impact of certain items that we do not consider indicative of our core operations. Adjusted EBITDA is determined by adding the following items to net (loss) income: interest expense, tax expense, depreciation and amortization, share-based compensation, loss on disposal of assets, impairment of goodwill and intangible assets, change in fair value of warrant liabilities, strategic branding initiatives and product launch expenses, co-manufacturing partner transition, and other non-recurring expenses.
We present Adjusted EBITDA as it is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. We believe that the disclosure of Adjusted EBITDA is useful to investors as this non-GAAP measure forms the basis of how our management team reviews and considers our operating results. By disclosing this non-GAAP measure, we believe that we create for investors a greater understanding of and an enhanced level of transparency into the means by which our management team operates our company. We also believe this measure can assist investors in comparing our performance to that of other companies on a consistent basis without regard to certain items that do not directly affect our ongoing operating performance or cash flows.
Adjusted EBITDA does not represent cash flows from operations as defined by GAAP. Adjusted EBITDA has limitations as a financial measure and you should not consider it in isolation, or as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including various cash flow metrics, net (loss) income, gross margin, and our other GAAP results.
The following table presents a reconciliation of net loss, the closest GAAP financial measure, to EBITDA and Adjusted EBITDA for each of the periods indicated (in thousands):
Reconciliation of Net Loss to EBITDA and Adjusted EBITDA (Dollars in thousands) |
||||||||||||||||
Three Months Ended December 31, |
Year Ended December 31, |
|||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Net loss available to common stockholders | $ | (14,701 | ) | $ | (24,362 | ) | $ | (22,770 | ) | $ | (39,316 | ) | ||||
Interest expense, net | 433 | 227 | 1,353 | 551 | ||||||||||||
Income tax expense | 2 | (22 | ) | 2 | (18 | ) | ||||||||||
Depreciation and amortization | 417 | 425 | 1,678 | 1,690 | ||||||||||||
EBITDA | (13,849 | )) | (23,732 | ) | (19,737 | ) | (37,093 | ) | ||||||||
Non-cash share-based compensation (a) | 157 | 515 | 1,775 | 2,969 | ||||||||||||
Impairment of goodwill | — | 18,614 | — | 18,614 | ||||||||||||
Impairment of intangible assets | 8,532 | — | 8,532 | — | ||||||||||||
Change in fair value of warrant liabilities | 1,575 | — | 236 | — | ||||||||||||
Loss on disposal of assets | 1 | 3 | 12 | 29 | ||||||||||||
Strategic branding initiatives and product launches (b) | 44 | (480 | ) | 128 | 1,046 | |||||||||||
Transaction related (c) | 137 | — | 935 | — | ||||||||||||
Other single occurrence expenses (d) | 46 | 264 | 149 | 2,654 | ||||||||||||
Adjusted EBITDA | $ | (3,359 | ) | $ | (4,819 | ) | $ | (7,973 | ) | $ | (11,781 | ) | ||||
(a) Non-cash expenses related to equity compensation awards. Share-based compensation is an important part of the Company’s compensation strategy and without our equity compensation plans, it is probable that salaries and other compensation related costs would be higher. | ||||||||||||||||
(b) Single occurrence expenses related to marketing agency and design, strategic re-branding initiatives, Elevate® launch, product innovation and reformulations. | ||||||||||||||||
(c) Transaction-related legal fees and professional fees related to single occurrence business matters. | ||||||||||||||||
(d) Reflects non-recurring launch expenses related to the Elevate® launch. | ||||||||||||||||
(e) Other single occurrence expenses such as legal settlements, employee severance, executive recruitment, transition of our dry kibble co-manufacturing supplier, and other non-recurring fees. | ||||||||||||||||
About Better Choice Company Inc.
Better Choice Company Inc. is a pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. We offer a broad portfolio of pet health and wellness products for dogs and cats sold under our Halo brand across multiple forms, including kibble, canned food, freeze-dried raw food and treats, vegan dog food and treats, oral care products, toppers and other chews and supplements. We have a demonstrated, multi-decade track record of success and are well positioned to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. Halo’s core products are made with high-quality, thoughtfully sourced ingredients for natural, science-based nutrition. Each innovative recipe is formulated with leading veterinary and nutrition experts to deliver optimal health. For more information, please visit https://www.betterchoicecompany.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Company Contact:
Better Choice Company Inc.
Kent Cunningham, CEO
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…